LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 10.06 | 770.25 | 1324 | 1218 | 1.0866 | 1.2674 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 12.28 | 770.25 | 1436 | 1358 | 1.0573 | 1.1410 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 12.28 | 770.25 | 1474 | 1358 | 1.0853 | 1.2105 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 14.50 | 770.25 | 1576 | 1497 | 1.0526 | 1.1098 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 14.50 | 770.25 | 1585 | 1497 | 1.0586 | 1.1224 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 16.73 | 770.25 | 1745 | 1664 | 1.0484 | 1.0868 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 16.73 | 770.25 | 1751 | 1664 | 1.0520 | 1.0933 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 18.95 | 770.25 | 1871 | 1832 | 1.0210 | 1.0335 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 18.95 | 770.25 | 1986 | 1832 | 1.0838 | 1.1329 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 21.17 | 770.25 | 2043 | 2008 | 1.0172 | 1.0249 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 21.17 | 770.25 | 2209 | 2008 | 1.0999 | 1.1426 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 23.39 | 770.25 | 2292 | 2244 | 1.0212 | 1.0273 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 23.39 | 770.25 | 2428 | 2244 | 1.0818 | 1.1045 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 25.62 | 770.25 | 2545 | 2514 | 1.0120 | 1.0140 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 25.62 | 770.25 | 2690 | 2514 | 1.0696 | 1.0804 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 27.84 | 770.25 | 2783 | 2833 | 0.9821 | 0.9808 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 27.84 | 770.25 | 2944 | 2833 | 1.0389 | 1.0410 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 30.06 | 770.25 | 3069 | 3106 | 0.9881 | 0.9881 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 30.06 | 770.25 | 3201 | 3106 | 1.0305 | 1.0301 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 32.28 | 770.25 | 3309 | 3392 | 0.9753 | 0.9767 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 32.28 | 770.25 | 3502 | 3392 | 1.0322 | 1.0298 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 34.50 | 770.25 | 3586 | 3712 | 0.9661 | 0.9698 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 34.50 | 770.25 | 3855 | 3712 | 1.0385 | 1.0336 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 36.73 | 770.25 | 3857 | 4086 | 0.9439 | 0.9526 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 36.73 | 770.25 | 4217 | 4086 | 1.0320 | 1.0264 | MN20160304_L02 | I11 |